Hikma Pharmaceuticals Share News (HIK)

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

LONDON MARKET OPEN: BT results disappoint; pound falls on Fed outlook

(Alliance News) - Stock prices in London opened lower on Thursday, as the pound fell against a strengthening dollar, after the Federal Reserve indicated that US interest rates are likely to reach higher levels than previously thought.

Hikma reiterates FY guidance amid 'strong momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceuticals reiterated full-year guidance on Thursday, citing "strong momentum" in its injectables and branded units, but also cautioned that had begun to see the effects of the global inflationary environment on costs.

LONDON BRIEFING: Stocks called down as markets brace for BoE hike

(Alliance News) - Stocks in London are set to open lower on Thursday, as the pressure is on for the Bank of England at midday, after the US Federal Reserve indicated interest rates are likely to have to reach a higher level than previously expected.

LONDON BROKER RATINGS: Upgrades for Vodafone, AJ Bell, B&M, Pennon

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Berenberg initiates coverage on Hikma Pharmaceuticals at 'hold'

(Sharecast News) - Analysts at Berenberg initiated coverage on drugmaker Hikma Pharmaceuticals at 'hold' on Tuesday, stating it was "waiting for the tide to turn".

LONDON BRIEFING: Pound, oil, gold up; Truss vows fiscal responsibility

(Alliance News) - Stocks in London are called higher on Tuesday, as the market watches closely for further clues regarding the UK's economic direction.

IN BRIEF: Hikma addresses gender imbalance with two new non-executives

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Appoints Laura Balan and Victoria Hull as independent non-executive directors with effect from October 1 and November 1, respectively. Balan worked for 17 years at the Capital Group Co, where she covered European healthcare and pharmaceutical sectors. Hull is currently a non-executive director for IQE PLC, Alphaware IP Group PLC and Network International Holdings PLC. Previously she was chief legal officer & executive director at Invensys PLC, now Schneider Electric, from 2001 to 2014.

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

UK dividends calendar - next 7 days